Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population.

Hinrichs C, Singh V, Xu G, Johnson SC; Alzheimers Disease Neuroimaging Initiative.

Neuroimage. 2011 Mar 15;55(2):574-89. doi: 10.1016/j.neuroimage.2010.10.081. Epub 2010 Dec 10.

2.

Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls.

Westman E, Simmons A, Zhang Y, Muehlboeck JS, Tunnard C, Liu Y, Collins L, Evans A, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Spenger C, Wahlund LO; AddNeuroMed consortium.

Neuroimage. 2011 Jan 15;54(2):1178-87. doi: 10.1016/j.neuroimage.2010.08.044. Epub 2010 Aug 25.

PMID:
20800095
3.

Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification.

Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ.

Neurobiol Aging. 2011 Dec;32(12):2322.e19-27. doi: 10.1016/j.neurobiolaging.2010.05.023. Epub 2010 Jul 1.

4.

Comparing predictors of conversion and decline in mild cognitive impairment.

Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR Jr, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2010 Jul 20;75(3):230-8. doi: 10.1212/WNL.0b013e3181e8e8b8. Epub 2010 Jun 30.

5.

Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database.

Cuingnet R, Gerardin E, Tessieras J, Auzias G, Lehéricy S, Habert MO, Chupin M, Benali H, Colliot O; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 May 15;56(2):766-81. doi: 10.1016/j.neuroimage.2010.06.013. Epub 2010 Jun 11.

PMID:
20542124
6.

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.

Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR Jr, Petersen RC, Aisen PS, Jagust WJ, Koeppe RA, Mathis CA, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2010 Aug;31(8):1284-303. doi: 10.1016/j.neurobiolaging.2010.05.003. Epub 2010 Jun 11.

7.

L2-norm multiple kernel learning and its application to biomedical data fusion.

Yu S, Falck T, Daemen A, Tranchevent LC, Suykens JA, De Moor B, Moreau Y.

BMC Bioinformatics. 2010 Jun 8;11:309. doi: 10.1186/1471-2105-11-309.

8.

MKL for robust multi-modality AD classification.

Hinrichs C, Singh V, Xu G, Johnson S.

Med Image Comput Comput Assist Interv. 2009;12(Pt 2):786-94.

9.

CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.

Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci. 2010 Feb 10;30(6):2088-101. doi: 10.1523/JNEUROSCI.3785-09.2010.

10.

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ.

Lancet Neurol. 2010 Jan;9(1):119-28. doi: 10.1016/S1474-4422(09)70299-6.

11.

Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.

Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, Hagler DJ Jr, Jennings RG, Karow D, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

AJNR Am J Neuroradiol. 2010 Feb;31(2):347-54. doi: 10.3174/ajnr.A1809. Epub 2010 Jan 14.

12.

Use of SVM methods with surface-based cortical and volumetric subcortical measurements to detect Alzheimer's disease.

Oliveira PP Jr, Nitrini R, Busatto G, Buchpiguel C, Sato JR, Amaro E Jr.

J Alzheimers Dis. 2010;19(4):1263-72. doi: 10.3233/JAD-2010-1322.

PMID:
20061613
13.

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.

Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Jul 28;73(4):294-301. doi: 10.1212/WNL.0b013e3181af79fb.

14.

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K.

JAMA. 2009 Jul 22;302(4):385-93. doi: 10.1001/jama.2009.1064.

PMID:
19622817
15.

Forecasting the global burden of Alzheimer's disease.

Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM.

Alzheimers Dement. 2007 Jul;3(3):186-91. doi: 10.1016/j.jalz.2007.04.381.

PMID:
19595937
16.

Spatially augmented LPboosting for AD classification with evaluations on the ADNI dataset.

Hinrichs C, Singh V, Mukherjee L, Xu G, Chung MK, Johnson SC; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2009 Oct 15;48(1):138-49. doi: 10.1016/j.neuroimage.2009.05.056. Epub 2009 May 27.

17.

Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging.

Gerardin E, Chételat G, Chupin M, Cuingnet R, Desgranges B, Kim HS, Niethammer M, Dubois B, Lehéricy S, Garnero L, Eustache F, Colliot O; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2009 Oct 1;47(4):1476-86. doi: 10.1016/j.neuroimage.2009.05.036. Epub 2009 May 20.

18.

Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease.

Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, Schmansky NJ, Greve DN, Salat DH, Buckner RL, Fischl B; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 Aug;132(Pt 8):2048-57. doi: 10.1093/brain/awp123. Epub 2009 May 21.

19.

Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve.

Querbes O, Aubry F, Pariente J, Lotterie JA, Démonet JF, Duret V, Puel M, Berry I, Fort JC, Celsis P; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 Aug;132(Pt 8):2036-47. doi: 10.1093/brain/awp105. Epub 2009 May 12.

20.

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Ann Neurol. 2009 Apr;65(4):403-13. doi: 10.1002/ana.21610.

Supplemental Content

Support Center